41.382 articles found

Botulinum toxin in the management of parkinsonian disorders.

Grippe T, Chen R.

Toxicon · 2023-07-08

DOI: 10.1016/j.toxicon.2023.107209PMID: 37429465

More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy.

Flores-Leon M, Outeiro TF.

Acta Neuropathol · 2023-07-08

DOI: 10.1007/s00401-023-02601-0PMID: 37421475

Exploring microglia and their phenomenal concatenation of stress responses in neurodegenerative disorders.

Asveda T, Talwar P, Ravanan P.

Life Sci · 2023-07-08

DOI: 10.1016/j.lfs.2023.121920PMID: 37429415

New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson's disease.

Gupta R, Kumari S, Senapati A, Ambasta RK, Kumar P.

Ageing Res Rev · 2023-07-08

DOI: 10.1016/j.arr.2023.102013PMID: 37429545

A Systematic Review of Diffusion Microstructure Imaging (Dmi): Current and Future Applications in Neurology Research

Mohammadi S, Ghaderi S.

· 2023-07-07

DOI: 10.2139/ssrn.4499590

Meta-Analysis of the Mechanisms Underlying COVID-19 Modulation of Parkinson’s Disease

Zhang J, Bishir M, Barbhuiya S, Chang SL.

· 2023-07-07

DOI: 10.20944/preprints202307.0476.v1

A Comparison of Cognitive Performance in Patients With Parkinson's Disease Psychosis According to Psychosis Severity: A Meta-Analysis

Gosse L, Pisani S, Velayudhan L, Ffytche D, Bhattacharyya S.

BJPsych open · 2023-07-07

The Effects of Rivastigmine on Neuropsychiatric Symptoms in the Early Stages of Parkinson's Disease: A Systematic Review

Reilly S, Dhaliwal S, Arshad U, Husain N, Macerollo A, Da Costa A.

BJPsych open · 2023-07-07

Dopamine agonists in Parkinson's disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment.

Isaacson SH, Hauser RA, Pahwa R, Gray D, Duvvuri S.

Clin Park Relat Disord · 2023-07-07

DOI: 10.1016/j.prdoa.2023.100212PMID: 37497384

Does Black vs. White race affect practitioners' appraisal of Parkinson's disease?

Harris S, Narayanan NS, Tranel D.

NPJ Parkinsons Dis · 2023-07-07

DOI: 10.1038/s41531-023-00549-2PMID: 37419894

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer's Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil.

Killick R, Elliott C, Ribe E, Broadstock M, Ballard C, Aarsland D, Williams G.

Int J Mol Sci · 2023-07-07

DOI: 10.3390/ijms241311219PMID: 37446396

Systematic Screening of Associations between Medication Use and Risk of Neurodegenerative Diseases Using a Mendelian Randomization Approach.

Wang W, Zhang L, Cao W, Xia K, Huo J, Huang T, Fan D.

Biomedicines · 2023-07-07

DOI: 10.3390/biomedicines11071930PMID: 37509570